UC DIS.CERT. 12/24 HNR1/ DE000HD13K19 /
14/06/2024 21:45:31 | Var.-1.330 | Denaro21:59:49 | Lettera21:59:49 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
208.270EUR | -0.63% | 208.200 Quantità in denaro: 200 |
208.340 Quantità in lettera: 200 |
HANNOVER RUECK SE NA... | - - | 31/12/2024 | Call |
GlobeNewswire
12:10
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Tr...
GlobeNewswire
11:30
Nurix Therapeutics Presents Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with...